+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 18Years +
All Genders
ID05099172

Open-Label Study of BAY2927088 in Advanced NSCLC Patients with EGFR or HER2 Mutations to Evaluate Safety and Dosage

Led by Bayer · Updated on 2026-10-21

430

Participants Needed

94

Research Sites

134 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating a new treatment for people with advanced non-small cell lung cancer NSCLC that has spread to nearby tissues or other parts of the body. The focus is on cancers with mutations in the genes that produce the proteins EGFR and HER2, which help cancer cells grow and spread. The study evaluates the safety, best dosage, and how the treatment moves through the body. It also aims to understand how well the treatment works in shrinking or eliminating cancer. The treatment being studied is called sevabertinib BAY2927088, given by mouth as a liquid or tablet once or twice daily in 3-week cycles. The study has four parts dose escalation to find the highest safe dose, backfill to test safe doses in more people, expansion to determine which dose to study further, and extension to assess treatment effectiveness. Participants will continue taking the treatment until their cancer worsens, they experience problems, or they leave the study. Participants will attend up to five visits per cycle where blood and urine samples are taken, scans like CT or MRI are done to check cancer status, and overall health including heart health is monitored. Researchers will track any medical problems or side effects, responses to treatment, and how the drug behaves in the body. The study follows participants for up to several years to monitor safety and treatment effects.

CONDITIONS

Brief Title

First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)

Research Team

B

Bayer Clinical Trials Contact

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here